GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Net Income (Continuing Operations)

Ectin Research AB (XSAT:ECTIN B) Net Income (Continuing Operations) : kr-16.92 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ectin Research AB's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was kr-2.30 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-16.92 Mil.

Ectin Research AB Net Income (Continuing Operations) Historical Data

The historical data trend for Ectin Research AB's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Net Income (Continuing Operations) Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Net Income (Continuing Operations)
-0.56 -1.20 -13.34 -17.23

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -1.34 -2.15 -11.13 -2.30

Ectin Research AB Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-16.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ectin Research AB  (XSAT:ECTIN B) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Ectin Research AB Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB (XSAT:ECTIN B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Net Income (Continuing Operations)
Comparable Companies
OSTO:QUIA XSAT:EUCI OSTO:LIDDS OSTO:PROMO OSTO:CLINE B OSTO:AMNI OSTO:REDW XSAT:ALTE OSTO:PHARM OSTO:DIABIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Website
https://www.ectinresearch.com
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines